
1. mol ther nucleic acids. 2016 apr 5;5:e303. doi: 10.1038/mtna.2016.14.

a novel p19 fusion protein delivery agent short-interfering rnas.

danielson dc(1), sachrajda n(2), wang w(3), filip r(3), pezacki jp(1)(2)(3).

author information: 
(1)department biochemistry, microbiology immunology, university ottawa,
ottawa, ontario, canada.
(2)department biology, university ottawa, ottawa, ontario, canada.
(3)department chemistry biomolecular sciences, university ottawa,
ottawa, ontario, canada.

rna interference (rnai) biological mechanism allows targeted gene
knockdown addition exogenous short-interfering rnas (sirnas) to
cells organisms. rnai revolutionized cell biology holds enormous
potential human therapy. one major challenges facing rnai therapy
is achieving efficient nontoxic delivery sirnas cell cytoplasm,
since highly anionic character precludes passage across cell
membrane unaided. herein, report novel fusion protein the
tombusviral p19 protein, binds sirnas picomolar affinity, the
"tat" peptide (rkkrrqrrrr), derived transactivator of
transcription (tat) protein human immunodeficiency virus acts a
cell-penetrating peptide. demonstrate fusion protein, 2x-p19-tat,
delivers sirnas cytoplasm human hepatoma cells elicit
potent sustained gene knockdown activity without toxic effects.

doi: 10.1038/mtna.2016.14 
pmcid: pmc5014518
pmid: 27045207 

